Remedies and preventives for antiphospholipid antibody syndrome
OwnerToshihiko Yamauchi, Hiromitsu Yokohama +2inventors
InventorsToshihiko Yamauchi, Hiromitsu Yokohama, Seiichi Kobayashi, Toshio Seto
Life of this patent
Estimating the term…
Abstract
Agents for treating and preventing antiphospholipid antibody syndrome (APS) comprising, as an active ingredient, a substance inhibiting interaction between gp39 on a T cell surface, which is a receptor mediating contact-dependent helper effector function, and CD40 on an antigen-presenting cell surface.
Claims4
An agent for treating antiphospholipid antibody syndrome (APS) comprising, as an active ingredient, a substance inhibiting interaction between gp39 on a T cell surface, which is a receptor mediating contact-dependent helper effector function, and CD40 on an antigen-presenting cell surface.
An agent for preventing antiphospholipid antibody syndrome (APS) comprising, as an active ingredient, a substance inhibiting interaction between gp39 on a T cell surface, which is a receptor mediating contact-dependent helper effector function, and CD40 on an antigen-presenting cell surface.
Dependencies are inferred from the claim text.